Cargando…

Achieving a timely diagnosis for teenagers and young adults with cancer: the ACE “too young to get cancer?” study

BACKGROUND: Time to diagnosis (TTD) concerns teenagers and young adults (TYA) with cancer and may affect outcome. METHODS: Healthcare records from 105 TYA in a regional cancer service were assessed to document events from 1st symptom to treatment start. Detailed pathway construction was possible for...

Descripción completa

Detalles Bibliográficos
Autores principales: Dommett, Rachel M., Pring, Hannah, Cargill, Jamie, Beynon, Paul, Cameron, Alison, Cox, Rachel, Nechowska, Aoife, Wint, Alison, Stevens, Michael C. G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6591830/
https://www.ncbi.nlm.nih.gov/pubmed/31234813
http://dx.doi.org/10.1186/s12885-019-5776-0
_version_ 1783429787450081280
author Dommett, Rachel M.
Pring, Hannah
Cargill, Jamie
Beynon, Paul
Cameron, Alison
Cox, Rachel
Nechowska, Aoife
Wint, Alison
Stevens, Michael C. G.
author_facet Dommett, Rachel M.
Pring, Hannah
Cargill, Jamie
Beynon, Paul
Cameron, Alison
Cox, Rachel
Nechowska, Aoife
Wint, Alison
Stevens, Michael C. G.
author_sort Dommett, Rachel M.
collection PubMed
description BACKGROUND: Time to diagnosis (TTD) concerns teenagers and young adults (TYA) with cancer and may affect outcome. METHODS: Healthcare records from 105 TYA in a regional cancer service were assessed to document events from 1st symptom to treatment start. Detailed pathway construction was possible for 104 patients and allowed a multidisciplinary panel review of each pathway with assessment of good practice and lessons for the future. RESULTS: 1st presentation was to primary care in 86, and 93% consulted in primary care before diagnosis. Routes to Diagnosis were 45% via urgent 2 Week Wait pathways and 38% as emergency referrals. Total Interval (time from 1st presentation to treatment start) was median 63 (range 1–559) days, varying within/between diagnoses. Patient interval (time from 1st symptom to 1st presentation) was longest for lymphoma, carcinoma and bone tumour (medians: 9, 12, 20 days). Overall, time in primary care was short (median 3, range 0–537 days) compared to secondary care (median 29, range 0–195 days) and longest for lymphoma, carcinoma, brain/CNS (medians: 10, 15, 16 days). Specialist Care interval (time from 1st specialist visit to treatment start) was longest for bone, brain/CNS, lymphoma, carcinoma (medians: 30, 33, 36, 48 days). 40% pathways were rated as showing good/best practice but 16% were less than satisfactory. Continued safety-netting/support was identified from primary care but analysis suggested opportunities for improvement in transition through secondary care. CONCLUSIONS: Previous reports of prolonged TTD have focused on delay in referral from primary care but this study suggests that this might be reduced by optimising management in secondary care.
format Online
Article
Text
id pubmed-6591830
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-65918302019-07-08 Achieving a timely diagnosis for teenagers and young adults with cancer: the ACE “too young to get cancer?” study Dommett, Rachel M. Pring, Hannah Cargill, Jamie Beynon, Paul Cameron, Alison Cox, Rachel Nechowska, Aoife Wint, Alison Stevens, Michael C. G. BMC Cancer Research Article BACKGROUND: Time to diagnosis (TTD) concerns teenagers and young adults (TYA) with cancer and may affect outcome. METHODS: Healthcare records from 105 TYA in a regional cancer service were assessed to document events from 1st symptom to treatment start. Detailed pathway construction was possible for 104 patients and allowed a multidisciplinary panel review of each pathway with assessment of good practice and lessons for the future. RESULTS: 1st presentation was to primary care in 86, and 93% consulted in primary care before diagnosis. Routes to Diagnosis were 45% via urgent 2 Week Wait pathways and 38% as emergency referrals. Total Interval (time from 1st presentation to treatment start) was median 63 (range 1–559) days, varying within/between diagnoses. Patient interval (time from 1st symptom to 1st presentation) was longest for lymphoma, carcinoma and bone tumour (medians: 9, 12, 20 days). Overall, time in primary care was short (median 3, range 0–537 days) compared to secondary care (median 29, range 0–195 days) and longest for lymphoma, carcinoma, brain/CNS (medians: 10, 15, 16 days). Specialist Care interval (time from 1st specialist visit to treatment start) was longest for bone, brain/CNS, lymphoma, carcinoma (medians: 30, 33, 36, 48 days). 40% pathways were rated as showing good/best practice but 16% were less than satisfactory. Continued safety-netting/support was identified from primary care but analysis suggested opportunities for improvement in transition through secondary care. CONCLUSIONS: Previous reports of prolonged TTD have focused on delay in referral from primary care but this study suggests that this might be reduced by optimising management in secondary care. BioMed Central 2019-06-24 /pmc/articles/PMC6591830/ /pubmed/31234813 http://dx.doi.org/10.1186/s12885-019-5776-0 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Dommett, Rachel M.
Pring, Hannah
Cargill, Jamie
Beynon, Paul
Cameron, Alison
Cox, Rachel
Nechowska, Aoife
Wint, Alison
Stevens, Michael C. G.
Achieving a timely diagnosis for teenagers and young adults with cancer: the ACE “too young to get cancer?” study
title Achieving a timely diagnosis for teenagers and young adults with cancer: the ACE “too young to get cancer?” study
title_full Achieving a timely diagnosis for teenagers and young adults with cancer: the ACE “too young to get cancer?” study
title_fullStr Achieving a timely diagnosis for teenagers and young adults with cancer: the ACE “too young to get cancer?” study
title_full_unstemmed Achieving a timely diagnosis for teenagers and young adults with cancer: the ACE “too young to get cancer?” study
title_short Achieving a timely diagnosis for teenagers and young adults with cancer: the ACE “too young to get cancer?” study
title_sort achieving a timely diagnosis for teenagers and young adults with cancer: the ace “too young to get cancer?” study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6591830/
https://www.ncbi.nlm.nih.gov/pubmed/31234813
http://dx.doi.org/10.1186/s12885-019-5776-0
work_keys_str_mv AT dommettrachelm achievingatimelydiagnosisforteenagersandyoungadultswithcancertheacetooyoungtogetcancerstudy
AT pringhannah achievingatimelydiagnosisforteenagersandyoungadultswithcancertheacetooyoungtogetcancerstudy
AT cargilljamie achievingatimelydiagnosisforteenagersandyoungadultswithcancertheacetooyoungtogetcancerstudy
AT beynonpaul achievingatimelydiagnosisforteenagersandyoungadultswithcancertheacetooyoungtogetcancerstudy
AT cameronalison achievingatimelydiagnosisforteenagersandyoungadultswithcancertheacetooyoungtogetcancerstudy
AT coxrachel achievingatimelydiagnosisforteenagersandyoungadultswithcancertheacetooyoungtogetcancerstudy
AT nechowskaaoife achievingatimelydiagnosisforteenagersandyoungadultswithcancertheacetooyoungtogetcancerstudy
AT wintalison achievingatimelydiagnosisforteenagersandyoungadultswithcancertheacetooyoungtogetcancerstudy
AT stevensmichaelcg achievingatimelydiagnosisforteenagersandyoungadultswithcancertheacetooyoungtogetcancerstudy